Listed

Cabaletta Bio, Inc.

CABANasdaqCIK 1759138HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$52.0m, Q2 FY2026
Net income−$51.0m, Q2 FY2026
Cabaletta Bio, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m13.8Research and development, Q3 FY2023, three months to 2023-09-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure17.4Research and development, Q4 FY2023, three months to 2023-12-31$17.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047201. Derived: 12-month figure less the 9-month figure.Report this figure22.0Research and development, Q1 FY2024, three months to 2024-03-31$22.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure23.4Research and development, Q2 FY2024, three months to 2024-06-30$23.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure26.3Research and development, Q3 FY2024, three months to 2024-09-30$26.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure25.5Research and development, Q4 FY2024, three months to 2024-12-31$25.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure29.0Research and development, Q1 FY2025, three months to 2025-03-31$29.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure37.6Research and development, Q2 FY2025, three months to 2025-06-30$37.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure39.8Research and development, Q3 FY2025, three months to 2025-09-30$39.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure36.2Research and development, Q4 FY2025, three months to 2025-12-31$36.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure37.4Research and development, Q1 FY2026, three months to 2026-03-31$37.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure44.4Research and development, Q2 FY2026, three months to 2026-06-30$44.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Operating income$m(18.7)Operating income, Q3 FY2023, three months to 2023-09-30−$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure(23.1)Operating income, Q4 FY2023, three months to 2023-12-31−$23.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047201. Derived: 12-month figure less the 9-month figure.Report this figure(28.0)Operating income, Q1 FY2024, three months to 2024-03-31−$28.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure(30.3)Operating income, Q2 FY2024, three months to 2024-06-30−$30.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure(33.0)Operating income, Q3 FY2024, three months to 2024-09-30−$33.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure(33.8)Operating income, Q4 FY2024, three months to 2024-12-31−$33.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(37.1)Operating income, Q1 FY2025, three months to 2025-03-31−$37.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure(45.9)Operating income, Q2 FY2025, three months to 2025-06-30−$45.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure(46.6)Operating income, Q3 FY2025, three months to 2025-09-30−$46.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure(42.6)Operating income, Q4 FY2025, three months to 2025-12-31−$42.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(44.3)Operating income, Q1 FY2026, three months to 2026-03-31−$44.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure(52.0)Operating income, Q2 FY2026, three months to 2026-06-30−$52.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Interest expense$mnot reportednot reported0.0Interest expense, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure0.7Interest expense, Q4 FY2024, three months to 2024-12-31$748.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2025, three months to 2025-03-31$294.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure0.6Interest expense, Q2 FY2025, three months to 2025-06-30$571.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure0.6Interest expense, Q3 FY2025, three months to 2025-09-30$584.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure0.6Interest expense, Q4 FY2025, three months to 2025-12-31$555.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2026, three months to 2026-03-31$636.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure0.5Interest expense, Q2 FY2026, three months to 2026-06-30$517.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figurenot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Net income$m(16.4)Net income, Q3 FY2023, three months to 2023-09-30−$16.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure(20.9)Net income, Q4 FY2023, three months to 2023-12-31−$20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047201. Derived: 12-month figure less the 9-month figure.Report this figure(25.0)Net income, Q1 FY2024, three months to 2024-03-31−$25.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure(27.6)Net income, Q2 FY2024, three months to 2024-06-30−$27.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure(30.6)Net income, Q3 FY2024, three months to 2024-09-30−$30.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure(32.6)Net income, Q4 FY2024, three months to 2024-12-31−$32.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(35.9)Net income, Q1 FY2025, three months to 2025-03-31−$35.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure(45.1)Net income, Q2 FY2025, three months to 2025-06-30−$45.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure(44.9)Net income, Q3 FY2025, three months to 2025-09-30−$44.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure(41.9)Net income, Q4 FY2025, three months to 2025-12-31−$41.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(43.5)Net income, Q1 FY2026, three months to 2026-03-31−$43.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure(51.0)Net income, Q2 FY2026, three months to 2026-06-30−$51.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Diluted EPS$ per share(0.37)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figurenot reported(0.51)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure(0.56)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure(0.62)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figurenot reported(0.71)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure(0.73)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure(0.44)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figurenot reported(0.39)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure(0.34)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Basic EPS$ per share(0.37)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figurenot reported(0.51)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure(0.56)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure(0.62)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figurenot reported(0.71)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure(0.73)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure(0.44)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figurenot reported(0.39)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure(0.34)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure

Balance sheet

Cash and equivalents$225.1m, Q2 FY2026
Shareholders' equity$210.6m, Q2 FY2026
Cabaletta Bio, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m116Cash and equivalents, Q3 FY2023, at 2023-09-30$115.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-061528.Report this figure193Cash and equivalents, FY2023, at 2023-12-31$193.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0000950170-25-047201.Report this figure175Cash and equivalents, Q1 FY2024, at 2024-03-31$175.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0000950170-24-060045.Report this figure179Cash and equivalents, Q2 FY2024, at 2024-06-30$178.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093325.Report this figure171Cash and equivalents, Q3 FY2024, at 2024-09-30$170.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure164Cash and equivalents, FY2024, at 2024-12-31$164.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-23, accession 0001759138-26-000011.Report this figure132Cash and equivalents, Q1 FY2025, at 2025-03-31$131.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure146Cash and equivalents, Q2 FY2025, at 2025-06-30$145.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure60.2Cash and equivalents, Q3 FY2025, at 2025-09-30$60.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure83.0Cash and equivalents, FY2025, at 2025-12-31$83.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure117Cash and equivalents, Q1 FY2026, at 2026-03-31$116.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure225Cash and equivalents, Q2 FY2026, at 2026-06-30$225.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Current assets$m166Current assets, Q3 FY2023, at 2023-09-30$166.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061528.Report this figure244Current assets, FY2023, at 2023-12-31$244.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047201.Report this figure227Current assets, Q1 FY2024, at 2024-03-31$227.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060045.Report this figure206Current assets, Q2 FY2024, at 2024-06-30$206.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093325.Report this figure186Current assets, Q3 FY2024, at 2024-09-30$185.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure167Current assets, FY2024, at 2024-12-31$166.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001759138-26-000011.Report this figure135Current assets, Q1 FY2025, at 2025-03-31$134.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure198Current assets, Q2 FY2025, at 2025-06-30$198.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure165Current assets, Q3 FY2025, at 2025-09-30$164.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure139Current assets, FY2025, at 2025-12-31$138.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure122Current assets, Q1 FY2026, at 2026-03-31$122.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure231Current assets, Q2 FY2026, at 2026-06-30$231.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Total assets$m173Total assets, Q3 FY2023, at 2023-09-30$173.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-061528.Report this figure254Total assets, FY2023, at 2023-12-31$253.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0000950170-25-047201.Report this figure240Total assets, Q1 FY2024, at 2024-03-31$240.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-060045.Report this figure217Total assets, Q2 FY2024, at 2024-06-30$217.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093325.Report this figure204Total assets, Q3 FY2024, at 2024-09-30$204.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure185Total assets, FY2024, at 2024-12-31$185.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001759138-26-000011.Report this figure165Total assets, Q1 FY2025, at 2025-03-31$165.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure225Total assets, Q2 FY2025, at 2025-06-30$224.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure190Total assets, Q3 FY2025, at 2025-09-30$189.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure165Total assets, FY2025, at 2025-12-31$165.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure148Total assets, Q1 FY2026, at 2026-03-31$148.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure257Total assets, Q2 FY2026, at 2026-06-30$256.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Current liabilities$m10.6Current liabilities, Q3 FY2023, at 2023-09-30$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061528.Report this figure16.0Current liabilities, FY2023, at 2023-12-31$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047201.Report this figure18.0Current liabilities, Q1 FY2024, at 2024-03-31$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060045.Report this figure17.9Current liabilities, Q2 FY2024, at 2024-06-30$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093325.Report this figure22.9Current liabilities, Q3 FY2024, at 2024-09-30$22.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure27.1Current liabilities, FY2024, at 2024-12-31$27.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001759138-26-000011.Report this figure34.0Current liabilities, Q1 FY2025, at 2025-03-31$34.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure41.5Current liabilities, Q2 FY2025, at 2025-06-30$41.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure45.7Current liabilities, Q3 FY2025, at 2025-09-30$45.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure50.2Current liabilities, FY2025, at 2025-12-31$50.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure41.5Current liabilities, Q1 FY2026, at 2026-03-31$41.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure39.9Current liabilities, Q2 FY2026, at 2026-06-30$39.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Total liabilities$m12.4Total liabilities, Q3 FY2023, at 2023-09-30$12.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-061528.Report this figure17.5Total liabilities, FY2023, at 2023-12-31$17.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0000950170-25-047201.Report this figure18.7Total liabilities, Q1 FY2024, at 2024-03-31$18.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-060045.Report this figure17.9Total liabilities, Q2 FY2024, at 2024-06-30$17.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093325.Report this figure30.2Total liabilities, Q3 FY2024, at 2024-09-30$30.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure32.7Total liabilities, FY2024, at 2024-12-31$32.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001759138-26-000011.Report this figure43.6Total liabilities, Q1 FY2025, at 2025-03-31$43.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure46.0Total liabilities, Q2 FY2025, at 2025-06-30$46.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104573.Report this figure50.3Total liabilities, Q3 FY2025, at 2025-09-30$50.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure53.0Total liabilities, FY2025, at 2025-12-31$53.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure44.8Total liabilities, Q1 FY2026, at 2026-03-31$44.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure46.1Total liabilities, Q2 FY2026, at 2026-06-30$46.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure
Shareholders' equity$m161Shareholders' equity, Q3 FY2023, at 2023-09-30$160.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-126733.Report this figure236Shareholders' equity, FY2023, at 2023-12-31$236.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001759138-26-000011.Report this figure222Shareholders' equity, Q1 FY2024, at 2024-03-31$221.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure200Shareholders' equity, Q2 FY2024, at 2024-06-30$199.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure174Shareholders' equity, Q3 FY2024, at 2024-09-30$174.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure152Shareholders' equity, FY2024, at 2024-12-31$152.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure122Shareholders' equity, Q1 FY2025, at 2025-03-31$121.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure178Shareholders' equity, Q2 FY2025, at 2025-06-30$178.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure139Shareholders' equity, Q3 FY2025, at 2025-09-30$139.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273280.Report this figure112Shareholders' equity, FY2025, at 2025-12-31$112.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure103Shareholders' equity, Q1 FY2026, at 2026-03-31$103.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure211Shareholders' equity, Q2 FY2026, at 2026-06-30$210.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure

Cash flow

Operating cash flow−$41.5m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Cabaletta Bio, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-126733. Derived: 9-month figure less the 6-month figure.Report this figure(16.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$16.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0000950170-25-047201. Derived: 12-month figure less the 9-month figure.Report this figure(24.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$24.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure(20.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$20.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104573. Derived: 6-month figure less the 3-month figure.Report this figure(20.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$20.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273280. Derived: 9-month figure less the 6-month figure.Report this figure(23.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$23.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(30.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$30.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure(30.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$30.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001759138-26-000039. Derived: 6-month figure less the 3-month figure.Report this figure(34.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$34.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273280. Derived: 9-month figure less the 6-month figure.Report this figure(35.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$35.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(42.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$42.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure(41.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$41.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001759138-26-000039. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$65.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-126733. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$185.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0000950170-25-047201. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$812.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0000950170-25-071971.Report this figure0.8Capital expenditure, Q2 FY2024, three months to 2024-06-30$770.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104573. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$253.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273280. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2024, three months to 2024-12-31$376.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2025, three months to 2025-03-31$785.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure0.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$161.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001759138-26-000039. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$78.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273280. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$205.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001759138-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001759138-26-000039. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)151.16m, Q2 FY2026
Cabaletta Bio, Inc., shares, quarterly
Line itemUnitQ1 FY20252025-03-31Q2 FY20252025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares50.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3150,743,101 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure61.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3061,876,586 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure112Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31112,025,474 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001759138-26-000026.Report this figure151Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30151,160,280 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure

Shares outstanding: 169.55mShares outstanding, period not labelled, at 2026-08-07169,545,445 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001759138-26-000039.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.